Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 20 | 2023 | 881 | 2.510 |
Why?
|
| Exercise | 13 | 2022 | 524 | 2.260 |
Why?
|
| Cognition | 9 | 2023 | 373 | 1.740 |
Why?
|
| Aged | 49 | 2023 | 6448 | 1.700 |
Why?
|
| Cognition Disorders | 6 | 2017 | 233 | 1.680 |
Why?
|
| Ischemia | 3 | 2014 | 45 | 1.410 |
Why?
|
| Apolipoprotein E4 | 5 | 2016 | 47 | 1.160 |
Why?
|
| Lower Extremity | 3 | 2016 | 38 | 1.100 |
Why?
|
| Middle Aged | 38 | 2022 | 9642 | 1.010 |
Why?
|
| Mortality | 5 | 2012 | 150 | 0.980 |
Why?
|
| Male | 50 | 2023 | 18870 | 0.950 |
Why?
|
| Aged, 80 and over | 21 | 2018 | 2333 | 0.930 |
Why?
|
| United States | 23 | 2017 | 3894 | 0.920 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2021 | 528 | 0.890 |
Why?
|
| Transportation of Patients | 1 | 2022 | 14 | 0.880 |
Why?
|
| Leisure Activities | 3 | 2012 | 31 | 0.880 |
Why?
|
| Humans | 63 | 2023 | 34853 | 0.880 |
Why?
|
| Health Status | 5 | 2012 | 356 | 0.870 |
Why?
|
| Female | 47 | 2023 | 19873 | 0.850 |
Why?
|
| Patient Participation | 1 | 2022 | 68 | 0.830 |
Why?
|
| Cholesterol, HDL | 3 | 2011 | 87 | 0.810 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 195 | 0.790 |
Why?
|
| Vascular Surgical Procedures | 3 | 2016 | 14 | 0.780 |
Why?
|
| Nutrition Surveys | 6 | 2017 | 228 | 0.770 |
Why?
|
| Cardiovascular Diseases | 4 | 2023 | 628 | 0.760 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2019 | 58 | 0.760 |
Why?
|
| Lipoproteins, LDL | 2 | 2019 | 61 | 0.730 |
Why?
|
| Hypertension | 7 | 2009 | 770 | 0.710 |
Why?
|
| Healthcare Disparities | 2 | 2014 | 446 | 0.700 |
Why?
|
| Patient Selection | 2 | 2017 | 154 | 0.680 |
Why?
|
| Limb Salvage | 3 | 2016 | 6 | 0.670 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 281 | 0.660 |
Why?
|
| Apolipoproteins E | 5 | 2018 | 129 | 0.640 |
Why?
|
| Multivariate Analysis | 9 | 2016 | 570 | 0.630 |
Why?
|
| Aging | 3 | 2011 | 639 | 0.620 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2014 | 16 | 0.590 |
Why?
|
| C-Reactive Protein | 3 | 2010 | 147 | 0.580 |
Why?
|
| Oxygen Consumption | 4 | 2015 | 98 | 0.570 |
Why?
|
| Muscle Stretching Exercises | 1 | 2015 | 2 | 0.540 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2015 | 4 | 0.540 |
Why?
|
| Treatment Outcome | 8 | 2016 | 1349 | 0.530 |
Why?
|
| Religion | 3 | 2009 | 77 | 0.510 |
Why?
|
| Health Services Accessibility | 3 | 2022 | 531 | 0.500 |
Why?
|
| Age Factors | 9 | 2016 | 1007 | 0.480 |
Why?
|
| Risk Factors | 13 | 2017 | 3414 | 0.470 |
Why?
|
| Blood Pressure | 6 | 2023 | 613 | 0.460 |
Why?
|
| Upper Extremity | 1 | 2013 | 7 | 0.460 |
Why?
|
| Genotype | 11 | 2018 | 641 | 0.460 |
Why?
|
| Activities of Daily Living | 2 | 2012 | 104 | 0.460 |
Why?
|
| Biomedical Research | 1 | 2017 | 371 | 0.460 |
Why?
|
| Apolipoprotein E2 | 2 | 2012 | 6 | 0.460 |
Why?
|
| Inpatients | 1 | 2013 | 72 | 0.450 |
Why?
|
| Diabetes Complications | 1 | 2013 | 91 | 0.440 |
Why?
|
| Vitamins | 1 | 2012 | 91 | 0.430 |
Why?
|
| Inflammation | 2 | 2023 | 577 | 0.420 |
Why?
|
| Cause of Death | 2 | 2013 | 154 | 0.420 |
Why?
|
| Genome-Wide Association Study | 6 | 2021 | 271 | 0.410 |
Why?
|
| Cotinine | 1 | 2011 | 40 | 0.410 |
Why?
|
| Coronary Disease | 1 | 2012 | 113 | 0.400 |
Why?
|
| Cohort Studies | 9 | 2015 | 1422 | 0.400 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 964 | 0.390 |
Why?
|
| Self Concept | 1 | 2011 | 136 | 0.380 |
Why?
|
| Exercise Therapy | 2 | 2016 | 64 | 0.380 |
Why?
|
| Population Surveillance | 1 | 2011 | 231 | 0.360 |
Why?
|
| Minority Groups | 1 | 2013 | 537 | 0.340 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2011 | 790 | 0.340 |
Why?
|
| Memory | 2 | 2022 | 165 | 0.330 |
Why?
|
| Cross-Sectional Studies | 7 | 2023 | 2561 | 0.330 |
Why?
|
| Body Composition | 3 | 2010 | 146 | 0.330 |
Why?
|
| Stroke | 1 | 2011 | 274 | 0.320 |
Why?
|
| Longitudinal Studies | 6 | 2011 | 841 | 0.310 |
Why?
|
| Interpersonal Relations | 1 | 2009 | 198 | 0.310 |
Why?
|
| Databases, Factual | 5 | 2016 | 288 | 0.310 |
Why?
|
| Motor Activity | 1 | 2010 | 393 | 0.310 |
Why?
|
| Health Surveys | 4 | 2010 | 358 | 0.300 |
Why?
|
| Adult | 18 | 2017 | 11034 | 0.300 |
Why?
|
| Primary Health Care | 1 | 2009 | 283 | 0.300 |
Why?
|
| Body Mass Index | 3 | 2006 | 775 | 0.300 |
Why?
|
| Genetic Counseling | 2 | 2017 | 10 | 0.290 |
Why?
|
| Statistics as Topic | 3 | 2015 | 111 | 0.290 |
Why?
|
| Comorbidity | 5 | 2016 | 606 | 0.290 |
Why?
|
| Time Factors | 6 | 2016 | 1681 | 0.280 |
Why?
|
| Physical Education and Training | 1 | 2006 | 22 | 0.280 |
Why?
|
| Hospitalization | 2 | 2013 | 370 | 0.280 |
Why?
|
| Cerebral Infarction | 1 | 2006 | 17 | 0.280 |
Why?
|
| Health Status Disparities | 1 | 2012 | 583 | 0.280 |
Why?
|
| Disclosure | 2 | 2017 | 31 | 0.280 |
Why?
|
| Religion and Medicine | 1 | 2006 | 18 | 0.280 |
Why?
|
| Educational Status | 2 | 2022 | 295 | 0.280 |
Why?
|
| Pilot Projects | 2 | 2019 | 628 | 0.280 |
Why?
|
| Nutrition Assessment | 1 | 2006 | 77 | 0.270 |
Why?
|
| Food Preferences | 1 | 2006 | 66 | 0.260 |
Why?
|
| Retrospective Studies | 6 | 2017 | 1961 | 0.260 |
Why?
|
| Anthropometry | 1 | 2005 | 91 | 0.260 |
Why?
|
| Smoking | 1 | 2011 | 903 | 0.250 |
Why?
|
| Risk Assessment | 5 | 2017 | 727 | 0.250 |
Why?
|
| Arteries | 2 | 2016 | 67 | 0.250 |
Why?
|
| Lipids | 1 | 2006 | 222 | 0.250 |
Why?
|
| Genetic Testing | 2 | 2017 | 71 | 0.250 |
Why?
|
| Insulin Resistance | 1 | 2006 | 177 | 0.240 |
Why?
|
| Critical Illness | 2 | 2014 | 37 | 0.240 |
Why?
|
| Hyperlipidemias | 1 | 2004 | 35 | 0.240 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 221 | 0.230 |
Why?
|
| Survival Rate | 3 | 2017 | 310 | 0.230 |
Why?
|
| Young Adult | 8 | 2017 | 4012 | 0.230 |
Why?
|
| Dementia | 2 | 2014 | 133 | 0.220 |
Why?
|
| Genetic Variation | 4 | 2013 | 328 | 0.220 |
Why?
|
| Amyloid | 1 | 2023 | 52 | 0.220 |
Why?
|
| Adolescent | 9 | 2014 | 5035 | 0.220 |
Why?
|
| Positron-Emission Tomography | 1 | 2023 | 79 | 0.220 |
Why?
|
| Heterozygote | 2 | 2016 | 91 | 0.220 |
Why?
|
| Mental Recall | 2 | 2012 | 73 | 0.210 |
Why?
|
| Homozygote | 2 | 2015 | 75 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 468 | 0.210 |
Why?
|
| Communication | 1 | 2022 | 170 | 0.200 |
Why?
|
| Postoperative Complications | 4 | 2016 | 206 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2015 | 638 | 0.190 |
Why?
|
| Triglycerides | 1 | 2019 | 129 | 0.180 |
Why?
|
| Chi-Square Distribution | 3 | 2016 | 213 | 0.180 |
Why?
|
| Proportional Hazards Models | 2 | 2011 | 423 | 0.180 |
Why?
|
| Incidence | 3 | 2014 | 882 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 592 | 0.170 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 465 | 0.160 |
Why?
|
| Heart Rate | 2 | 2018 | 248 | 0.160 |
Why?
|
| Sex Factors | 3 | 2014 | 859 | 0.160 |
Why?
|
| Telephone | 1 | 2017 | 32 | 0.160 |
Why?
|
| Airway Obstruction | 1 | 2017 | 9 | 0.160 |
Why?
|
| Plasma Exchange | 1 | 2017 | 5 | 0.150 |
Why?
|
| Albumins | 1 | 2017 | 24 | 0.150 |
Why?
|
| Brain | 2 | 2023 | 1268 | 0.150 |
Why?
|
| Obesity | 2 | 2007 | 965 | 0.150 |
Why?
|
| Forecasting | 1 | 2017 | 124 | 0.150 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 71 | 0.140 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2015 | 82 | 0.140 |
Why?
|
| Odds Ratio | 3 | 2016 | 517 | 0.140 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 81 | 0.140 |
Why?
|
| Alleles | 1 | 2016 | 284 | 0.140 |
Why?
|
| Antihypertensive Agents | 2 | 2009 | 284 | 0.140 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2014 | 4 | 0.130 |
Why?
|
| Haplotypes | 2 | 2006 | 152 | 0.130 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2014 | 6 | 0.130 |
Why?
|
| Hippocampus | 1 | 2018 | 546 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 147 | 0.130 |
Why?
|
| Lung | 1 | 2017 | 413 | 0.120 |
Why?
|
| Neuropsychological Tests | 3 | 2023 | 255 | 0.120 |
Why?
|
| Survival Analysis | 2 | 2013 | 322 | 0.120 |
Why?
|
| Surgical Wound Infection | 1 | 2013 | 15 | 0.120 |
Why?
|
| Length of Stay | 1 | 2014 | 184 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2015 | 420 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2015 | 490 | 0.110 |
Why?
|
| Prevalence | 2 | 2010 | 1425 | 0.110 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2012 | 19 | 0.110 |
Why?
|
| Geriatric Assessment | 1 | 2012 | 52 | 0.110 |
Why?
|
| Office Visits | 1 | 2011 | 22 | 0.100 |
Why?
|
| Publishing | 1 | 2011 | 25 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 600 | 0.100 |
Why?
|
| Logistic Models | 2 | 2014 | 894 | 0.100 |
Why?
|
| Animals | 3 | 2016 | 14307 | 0.100 |
Why?
|
| Survival | 1 | 2010 | 8 | 0.100 |
Why?
|
| Cats | 1 | 2010 | 65 | 0.090 |
Why?
|
| Cardiovascular Deconditioning | 1 | 2010 | 1 | 0.090 |
Why?
|
| Thrombin | 1 | 2010 | 24 | 0.090 |
Why?
|
| Physical Exertion | 1 | 2010 | 25 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2010 | 151 | 0.090 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 43 | 0.090 |
Why?
|
| Dogs | 1 | 2010 | 138 | 0.090 |
Why?
|
| Case-Control Studies | 4 | 2015 | 1056 | 0.090 |
Why?
|
| Physical Fitness | 1 | 2010 | 78 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2013 | 469 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2009 | 136 | 0.090 |
Why?
|
| Apoptosis | 1 | 2016 | 1317 | 0.090 |
Why?
|
| Insurance Coverage | 1 | 2009 | 99 | 0.090 |
Why?
|
| Tobacco, Smokeless | 1 | 2009 | 18 | 0.090 |
Why?
|
| Sodium | 2 | 2007 | 101 | 0.090 |
Why?
|
| Stem Cells | 1 | 2010 | 132 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 92 | 0.090 |
Why?
|
| Risk | 2 | 2013 | 256 | 0.080 |
Why?
|
| Health Services Needs and Demand | 1 | 2009 | 143 | 0.080 |
Why?
|
| Hospital Mortality | 3 | 2014 | 183 | 0.080 |
Why?
|
| Particle Size | 1 | 2008 | 200 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 233 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 229 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 220 | 0.080 |
Why?
|
| District of Columbia | 2 | 2005 | 68 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2010 | 296 | 0.070 |
Why?
|
| Aldosterone | 1 | 2007 | 62 | 0.070 |
Why?
|
| Angiotensinogen | 1 | 2006 | 5 | 0.070 |
Why?
|
| Area Under Curve | 1 | 2006 | 91 | 0.070 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2006 | 24 | 0.070 |
Why?
|
| Life Style | 1 | 2008 | 288 | 0.070 |
Why?
|
| Gene Frequency | 1 | 2006 | 155 | 0.070 |
Why?
|
| Diet Records | 1 | 2006 | 56 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2009 | 375 | 0.070 |
Why?
|
| Fishes | 1 | 2006 | 48 | 0.070 |
Why?
|
| Muscles | 1 | 2005 | 64 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 165 | 0.060 |
Why?
|
| Base Composition | 1 | 2004 | 22 | 0.060 |
Why?
|
| Thymine | 1 | 2004 | 25 | 0.060 |
Why?
|
| Adenine | 1 | 2004 | 43 | 0.060 |
Why?
|
| Point Mutation | 1 | 2004 | 88 | 0.060 |
Why?
|
| Guanine | 1 | 2004 | 45 | 0.060 |
Why?
|
| Insulin | 1 | 2006 | 224 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2006 | 333 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2010 | 874 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 1003 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 1 | 2003 | 125 | 0.060 |
Why?
|
| Body Weight | 1 | 2005 | 404 | 0.060 |
Why?
|
| alpha-Synuclein | 1 | 2023 | 48 | 0.060 |
Why?
|
| Age of Onset | 2 | 2013 | 98 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2023 | 140 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 157 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2021 | 70 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2023 | 1353 | 0.040 |
Why?
|
| Anxiety | 2 | 2016 | 705 | 0.040 |
Why?
|
| Spirometry | 1 | 2017 | 33 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2017 | 38 | 0.040 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2017 | 1 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2017 | 68 | 0.040 |
Why?
|
| Reoperation | 1 | 2016 | 22 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 2015 | 5 | 0.040 |
Why?
|
| Indiana | 1 | 2015 | 15 | 0.030 |
Why?
|
| Chicago | 1 | 2015 | 24 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 243 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 102 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 56 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2014 | 43 | 0.030 |
Why?
|
| Caribbean Region | 1 | 2014 | 63 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2014 | 196 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 58 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2013 | 92 | 0.030 |
Why?
|
| Apolipoprotein E3 | 1 | 2011 | 10 | 0.030 |
Why?
|
| Authorship | 1 | 2011 | 5 | 0.030 |
Why?
|
| Health Behavior | 1 | 2016 | 491 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2012 | 149 | 0.030 |
Why?
|
| Visual Cortex | 1 | 2012 | 58 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 53 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2012 | 108 | 0.030 |
Why?
|
| Genomics | 1 | 2012 | 201 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2012 | 193 | 0.020 |
Why?
|
| Forearm | 1 | 2010 | 9 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2016 | 541 | 0.020 |
Why?
|
| Sample Size | 1 | 2010 | 28 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 47 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 31 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 129 | 0.020 |
Why?
|
| Depression | 1 | 2016 | 664 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 528 | 0.020 |
Why?
|
| Spirituality | 1 | 2008 | 43 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2010 | 287 | 0.020 |
Why?
|
| Abdominal Fat | 1 | 2007 | 21 | 0.020 |
Why?
|
| Potassium | 1 | 2007 | 110 | 0.020 |
Why?
|
| Exercise Test | 1 | 2007 | 68 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2006 | 33 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 968 | 0.020 |
Why?
|
| Family Health | 1 | 2004 | 47 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 2004 | 30 | 0.020 |
Why?
|
| Oxygen | 1 | 2004 | 193 | 0.010 |
Why?
|
| Parents | 1 | 2004 | 288 | 0.010 |
Why?
|